McKechnie Duncan 4

What Happened

• McKechnie Duncan, EVP & Chief Commercial Officer of Vertex Pharmaceuticals (VRTX), had 1,127 shares disposed/withheld to satisfy tax withholding related to an option exercise. The withholding price was $468.41 per share for a total of $527,898. This is a routine tax-withholding disposition rather than an open-market sale.

Key Details

• Transaction date: 2026-02-10; filing date: 2026-02-12 (filed within the typical 2-business-day window).
• Price per share: $468.41; shares withheld/disposed: 1,127; total value: $527,898.
• Shares owned after transaction: not disclosed in the information provided in this Form 4.
• Transaction code: F — shares withheld to satisfy tax withholding obligation (related to an option exercise), not a market sale.

Context

• This filing reflects tax withholding tied to an option exercise (a common post-exercise step). Withheld/surrendered shares are used to cover tax liabilities and do not necessarily indicate a decision to sell shares on the open market or signal insider sentiment.